Oramed Pharmaceuticals Stock (NASDAQ:ORMP), Quotes and News Summary

Q: What sector and industry does Oramed Pharmaceuticals (ORMP) operate in?

Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Oramed Pharmaceuticals Stock (NASDAQ: ORMP) stock price, news, charts, stock research, profile.

Open	$2.340
Close	$2.370
Volume / Avg.	40.834K / 169.509K
Day Range	2.305 - 2.390
52 Wk Range	1.670 - 5.250
Market Cap	$100.082M
P/E Ratio	16.929
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	1.59%
Days to Cover	4.59

Recent News

Top 4 Health Care Stocks That May Crash This Quarter

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Avi Kapoor

Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.

Lisa Levin

Dow Tumbles 250 Points; CarMax Posts Upbeat Results

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday. Following the market opening Friday, the Dow traded down 0.74% to 33,695.28 while the NASDAQ fell 0.98% to 13,497.22. The S&P 500, also fell, dropping, 0.78% to 4,347.58.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Oramed Pharmaceuticals, Inc

Sector

Health Care

Industry

Pharmaceuticals

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and developme...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Oramed Pharmaceuticals (ORMP) stock?

You can purchase shares of Oramed Pharmaceuticals (NASDAQ: ORMP) through any online brokerage.

View our list of the best stock brokerages.

Who are Oramed Pharmaceuticals's (ORMP) competitors?

Other companies in Oramed Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Rani Therapeutics Hldgs (NASDAQ:RANI), Marinus Pharma (NASDAQ:MRNS), Alimera Sciences (NASDAQ:ALIM) and Telomir Pharmaceuticals (NASDAQ:TELO).

What is the target price for Oramed Pharmaceuticals (ORMP) stock?

The latest price target for Oramed Pharmaceuticals (NASDAQ: ORMP) was reported by Canaccord Genuity on Wednesday, May 17, 2023. The analyst firm set a price target for 2.00 expecting ORMP to fall to within 12 months (a possible -19.03% downside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Oramed Pharmaceuticals (ORMP)?

The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $2.47 last updated April 22, 2024 at 7:56 PM EDT.

Does Oramed Pharmaceuticals (ORMP) pay a dividend?

There are no upcoming dividends for Oramed Pharmaceuticals.

When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?

Oramed Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Oramed Pharmaceuticals (ORMP) going to split?

There is no upcoming split for Oramed Pharmaceuticals.

What sector and industry does Oramed Pharmaceuticals (ORMP) operate in?

Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-